Sunday, February 17, 2013 Saturday, February 16, 2013 Friday, February 15, 2013 Thursday, February 14, 2013- Boys Getting Cervical Cancer Shots in Australia Boosts Gardasilat Bloomberg (Thu, Feb 14)
- News Summary: Merck settles cholesterol drug suitsAP (Thu, Feb 14)
- Merck settles investor suits on cholesterol drugsAP (Thu, Feb 14)
- P&G expects $200M to $275M in Venezuela chargesAP (Thu, Feb 14)
- Merck's Dynamic Duoat Motley Fool (Thu, Feb 14)
- Merck to Pay $688 Million to Settle Vytorin Litigationat Bloomberg (Thu, Feb 14)
- Merck to Pay $688 Million to Settle Class Action Lawsuitsat Motley Fool (Thu, Feb 14)
- Venezuela to Limit Medicine Prices After Chavez Devaluationat Bloomberg (Thu, Feb 14)
- Merck to pay $688 million to settle Enhance shareholder suitsat bizjournals.com (Thu, Feb 14)
- Why Venezuela's Devaluation Is Bitingat CNBC (Thu, Feb 14)
- P&G Employs Crowdfunding and 2 Dow Movers to Followat Wall St. Cheat Sheet (Thu, Feb 14)
- Dow Today: Merck (MRK) Lowerat TheStreet (Thu, Feb 14)
- Hedge Fund Kahn Brothers’ Stock Picks for 2013at Motley Fool (Thu, Feb 14)
- Merck Pays $688M To Settle Investor Suit on Enhance Trialat Fox Business (Thu, Feb 14)
- Merck To Pay $688 Million To Shareholders For Delaying Vytorin Resultsat Forbes (Thu, Feb 14)
- Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE TrialBusiness Wire (Thu, Feb 14)
Wednesday, February 13, 2013Add MRK News to My Yahoo!  | |
|